POOLBEG PHARMA Plc

Awarded €2.3m in non-dilutive funding to progress Oral Vaccine Platform

By Elric Langton | 15 November 2022

I have a financial interest in Poolbeg Pharma.

Poolbeg Pharma (AIM: POLB OTCQB: POLBF) is developing some juicy newsflow this month. Today the clinical-stage infectious disease pharmaceutical company announced it had been awarded €2.3m (over three years - unsure of the split), a milestone, the first non-dilutive funding…